Survival and morbidity following stereotactic radiotherapy of hepatocellular carcinoma: a ten-year, single institution experience-Reference-Cited by-同舟云学术

Survival and morbidity following stereotactic radiotherapy of hepatocellular carcinoma: a ten-year, single institution experience

Published:2021-01-12 Issue:3 Volume:56 Page:259-265
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Mortensen Hanna Rahbek¹²,Villadsen Gerda Elisabeth³,Worm Esben Schjødt⁴,Weber Britta¹²

Affiliation:

1. Department of Oncology, Aarhus University Hospital, Aarhus, Denmark

2. Danish Center of Particle Therapy, Aarhus University Hospital, Aarhus, Denmark

3. Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark

4. Department of Medical Physics, Aarhus University Hospital, Aarhus, Denmark

Funder

Danish National Research Center for Radiotherapy

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2020.1869822

Reference39 articles.

1. NORDCAN - Kræftstatistik for de nordiske lande. [cited 2020 Oct 20]. Available from: www.dep.iarc.fr/NORDCAN/DK

2. Kliniske retningslinjer for udredning og behandling af HCC. [cited 2020 Oct 20]. Available from: http://www.gicancer.dk/kliniskeretningslinjerHCC.docx

3. Rekommandationer for udførelse af stereotaktisk strålebehandling af tumorer i leveren. [cited 2020 Oct 20]. Available from: http://www.gicancer.dk/Retningslinier_DLGCG/Radioterapiudvalg.pdf

4. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

5. Partial Volume Tolerance of the Liver to Radiation

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibiting p21-activated kinase (PAK7) enhances radiosensitivity in hepatocellular carcinoma;Human & Experimental Toxicology;2021-06-24